SciSparc SPRC
NASDAQ SPRC
$4.61 -0.09 (-2.02%)
As of: Sep 30, 2026 · 10:13 AM EDT

SciSparc (SPRC) Operating Leases (2019 - 2025)

Updated

SciSparc (SPRC) reported Operating Leases of $25,000 for Q2 2025, down 34.2% from $38,000 a year earlier.

Analysis

SciSparc (SPRC) Operating Leases (2019 - 2025) Analysis & Trends

At the end of FY2024, SciSparc posted Operating Leases of $9,000, down 82.7% from FY2023.

  • Operating Leases has a five-year compound annual growth rate of -37.5% (FY2019 to FY2024).
  • By year, Operating Leases came in at $52,000 in FY2023 (+92.6%), $27,000 in FY2022 (-40.0%) and $45,000 in FY2021.
  • Five-year quarterly Operating Leases spans a low of $9,000 in Q4 2024 and a high of $1.71 million in Q2 2023.
  • Year over year, Operating Leases gained in 1 of the last four quarters, with an average decline of 30.5%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 SciSparc 609,748.33 1.52 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 25,000.00
Dec 31, 2024 9,000.00
Jun 30, 2024 38,000.00
Dec 31, 2023 52,000.00
Jun 30, 2023 1.71 Mn
Dec 31, 2022 27,000.00
Jun 30, 2022 45,000.00
Dec 31, 2021 45,000.00
Dec 31, 2019 94,000.00
Jun 30, 2019 116,000.00
API Access

SciSparc Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=SPRC&period=max&api_key=YOUR_API_KEY